These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27978994)

  • 1. Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor.
    Bayin NS; Ma L; Thomas C; Baitalmal R; Sure A; Fansiwala K; Bustoros M; Golfinos JG; Pacione D; Snuderl M; Zagzag D; Barcellos-Hoff MH; Placantonakis D
    Neoplasia; 2016 Dec; 18(12):795-805. PubMed ID: 27978994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β.
    Hardee ME; Marciscano AE; Medina-Ramirez CM; Zagzag D; Narayana A; Lonning SM; Barcellos-Hoff MH
    Cancer Res; 2012 Aug; 72(16):4119-29. PubMed ID: 22693253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of the DNA damage response by transforming growth factor-beta inhibitors enhances radiation sensitivity of non-small-cell lung cancer cells in vitro and in vivo.
    Du S; Bouquet S; Lo CH; Pellicciotta I; Bolourchi S; Parry R; Barcellos-Hoff MH
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):91-9. PubMed ID: 25835621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
    Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision Medicine with TGF-β Inhibition Using Tumor Explants: Comment on "Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor" by N. Sumru Bayin et al.
    Huang H; Yu JS
    Neoplasia; 2016 Dec; 18(12):806-807. PubMed ID: 27978995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Radioresponse and Radiosensitizers in Glioblastoma Organotypic Cultures.
    Bayin NS; Ma L; Placantonakis DG; Barcellos-Hoff MH
    Methods Mol Biol; 2018; 1741():171-182. PubMed ID: 29392699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of EGFR Inactivation on the Radiation Response in High Grade Glioma.
    Alexandru O; Purcaru SO; Tataranu LG; Lucan L; Castro J; Folcuţi C; Artene SA; Tuţă C; Dricu A
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29329222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells.
    Tritschler I; Gramatzki D; Capper D; Mittelbronn M; Meyermann R; Saharinen J; Wick W; Keski-Oja J; Weller M
    Int J Cancer; 2009 Aug; 125(3):530-40. PubMed ID: 19431147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual targeting of IGF-1R and PDGFR inhibits proliferation in high-grade gliomas cells and induces radiosensitivity in JNK-1 expressing cells.
    Carapancea M; Cosaceanu D; Budiu R; Kwiecinska A; Tataranu L; Ciubotaru V; Alexandru O; Banita M; Pisoschi C; Bäcklund ML; Lewensohn R; Dricu A
    J Neurooncol; 2007 Dec; 85(3):245-54. PubMed ID: 17568996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 IGF receptor associates with adverse outcome and cellular radioresistance in paediatric high-grade glioma.
    Simpson AD; Soo YWJ; Rieunier G; Aleksic T; Ansorge O; Jones C; Macaulay VM
    Br J Cancer; 2020 Mar; 122(5):624-629. PubMed ID: 31857716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
    Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
    Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.
    Tran TT; Uhl M; Ma JY; Janssen L; Sriram V; Aulwurm S; Kerr I; Lam A; Webb HK; Kapoun AM; Kizer DE; McEnroe G; Hart B; Axon J; Murphy A; Chakravarty S; Dugar S; Protter AA; Higgins LS; Wick W; Weller M; Wong DH
    Neuro Oncol; 2007 Jul; 9(3):259-70. PubMed ID: 17522330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-Derived Growth Factor Receptor and Ionizing Radiation in High Grade Glioma Cell Lines.
    Alexandru O; Sevastre AS; Castro J; Artene SA; Tache DE; Purcaru OS; Sfredel V; Tataranu LG; Dricu A
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Glucose Metabolism of Cancer Cells with Dichloroacetate to Radiosensitize High-Grade Gliomas.
    Cook KM; Shen H; McKelvey KJ; Gee HE; Hau E
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioma SOX2 expression decreased after adjuvant therapy.
    Yu W; Ren X; Hu C; Tan Y; Shui Y; Chen Z; Zhang L; Peng J; Wei Q
    BMC Cancer; 2019 Nov; 19(1):1087. PubMed ID: 31718604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF beta signaling and its role in glioma pathogenesis.
    Kaminska B; Kocyk M; Kijewska M
    Adv Exp Med Biol; 2013; 986():171-87. PubMed ID: 22879069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligosaccharyltransferase Inhibition Reduces Receptor Tyrosine Kinase Activation and Enhances Glioma Radiosensitivity.
    Baro M; Lopez Sambrooks C; Quijano A; Saltzman WM; Contessa J
    Clin Cancer Res; 2019 Jan; 25(2):784-795. PubMed ID: 29967251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGFR2 expression and TGF-β signaling in initial and recurrent high-grade human glioma.
    Kuczynski EA; Patten SG; Coomber BL
    Oncology; 2011; 81(2):126-34. PubMed ID: 21985798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.